HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].

Abstract
Amphotericin B remains an important antifungal agent in the treatment of ocular mycosis. Since topical ocular application is limited because of ocular irritation and poor penetration, we studied the pharmacokinetics of amphotericin B encapsulated in unilamellar liposomes (AmBisome). One drop (20 microliters) of AmBisome or an equivalent concentration of amphotericin B was applied to rabbit eyes. Drug concentrations were measured 15, 60, 120 and 240 min following administration of the agents by HPLC in cornea and aqueous humor. The effect of intact (group A) and debrided corneal epithelium (group B) was also studied. Corneal amphotericin B levels were significantly higher (P < 0.01) after 15 min in animals receiving amphotericin B as compared to AmBisome in group A. At later time points no differences in the corneal drug levels were found, and the drug levels following AmBisome application were remarkably stable. Epithelial removal resulted in increased corneal drug levels following application of both amphotericin B preparations. Significantly higher drug levels were observed after free amphotericin B treatment at 15-60 min (P < 0.01). Drug levels in the aqueous humor did not differ between the two amphotericin B preparations and remained below therapeutically effective concentrations. These results suggest that topically delivered AmBisome provides stable corneal drug levels, but has the potential benefit of lowered ocular toxicity.
AuthorsU Pleyer, J Grammer, J H Pleyer, P Kosmidis, D Friess, K H Schmidt, H J Thiel
JournalDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (Ophthalmologe) Vol. 92 Issue 4 Pg. 469-75 (Aug 1995) ISSN: 0941-293X [Print] Germany
Vernacular TitleAmphotericin B--Wirkspiegel in der Kornea. Untersuchungen zur lokalen Anwendung von liposomal-inkorporiertem Amphotericin B.
PMID7549331 (Publication Type: Comparative Study, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Ophthalmic Solutions
  • liposomal amphotericin B
  • Amphotericin B
Topics
  • Amphotericin B (administration & dosage, pharmacokinetics)
  • Animals
  • Antifungal Agents (administration & dosage, pharmacokinetics)
  • Cornea (drug effects, metabolism)
  • Ophthalmic Solutions
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: